Welcome to LookChem.com Sign In|Join Free

CAS

  • or

288159-40-0

Post Buying Request

288159-40-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

288159-40-0 Usage

Chemical Properties

White powder

Check Digit Verification of cas no

The CAS Registry Mumber 288159-40-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,8,1,5 and 9 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 288159-40:
(8*2)+(7*8)+(6*8)+(5*1)+(4*5)+(3*9)+(2*4)+(1*0)=180
180 % 10 = 0
So 288159-40-0 is a valid CAS Registry Number.

288159-40-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H52825)  N-Boc-3-hydroxy-D-valine, 97%   

  • 288159-40-0

  • 250mg

  • 2470.0CNY

  • Detail
  • Alfa Aesar

  • (H52825)  N-Boc-3-hydroxy-D-valine, 97%   

  • 288159-40-0

  • 1g

  • 7409.0CNY

  • Detail

288159-40-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R)-3-hydroxy-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid

1.2 Other means of identification

Product number -
Other names N-Boc-3-hydroxy-D-valine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:288159-40-0 SDS

288159-40-0Downstream Products

288159-40-0Relevant articles and documents

NIPECOTIC ACID DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES

-

, (2015/03/03)

The present invention aims to provide a compound having an sEH-inhibiting activity and to provide a pharmaceutical having a therapeutic effect and a prophylactic effect on chronic renal disease and pulmonary hypertension based on the sEH-inhibiting action. The present invention provides nipecotic acid derivatives represented by the chemical formula below and pharmaceutically acceptable salts thereof.

Serine as chiral educt for the practical synthesis of enantiopure N-protected β-hydroxyvaline

Dettwiler, James E.,Lubell, William D.

, p. 177 - 179 (2007/10/03)

N-tert-Butyloxycarbonyl- and N-benzenesulfonyl-β-hydroxyvalines 1a and 1b were, respectively, synthesized in enantiomerically pure form by a two-step protocol from their enantiomeric N-protected serine methyl esters 2a and 2b. The addition of CH3MgBr to 2a and 2b provided diols 3a and 3b, respectively as major products in 83% and 81% yields. Selective oxidation of diols 3a and 3b was performed using a TEMPO, NaClO2, NaOCl cocktail in 96% and 93% respective yields. This two-step process effectively furnished multigram amounts of enantiopure N-Boc-β-hydroxyvaline 1a.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 288159-40-0